Los analistas hablan de una fiebre del oro de la obesidad y consideran que el mercado de GLP-1 podra alcanzar los 150.000 millones de dlares en 2031 (una cifra similar al beneficio de la mayor petrolera del mundo o a lo que mueven los medicamentos para el cncer)
While their therapeutic benefits are well-established, the relationship between GLP-1RAs and cancer risk has become a critical focus of clinical investigation
Gallbladder issues Gallbladder issues and gallstones are a recognized risk with GLP-1 medications, particularly with significant rapid weight loss
Inoue T, Inoguchi T, Sonoda N, Hendarto H, Makimura H, Sasaki S, Yokomizo H, Fujimura Y, Miura D, Takayanagi R
The future of healthcare is being shaped by scientific advancement, regulatory expansion, and global collaboration
quick-service spending down about 8 percent